patients had their tumors reduced by at least 50 percent while 20 percent saw their tumors reduced by less than 50 percent.
Another study presented at the conference showed that Herceptin, a treatment that blocks the production of the HER2 protein which in excess can cause tumors to return, does not enhance the long-term danger of heart attacks. "While we need to continue monitoring patients closely for late cardiac effect, this is reassuring news for women taking this drug," said Priya Rastogi, assistant professor of medicine at the University of Pittsburgh.
Compared to other cancers, there has been marked progress in the fight against breast cancer, particularly because of targeted treatments. But gains in survival rates, with a 2.3 percent reduction in deaths recorded in recent years, have not been shared equally in the United States among African-Americans and whites, said a new study published Sunday.
For women diagnosed between 1999 and 2003, whites survived for a median of 27 months compared to 17 months for black patients -- an eight percent difference, said the study by researchers at the University of Texas. More than 180,510 Americans will be diagnosed with breast cancer in 2008 and about 41,000 will die from the disease, according to the American Cancer Society.
'"/>Page: 1 2 Related medicine news :1.
Advanced STD programs required 2.
Hope For Patients With Advanced Breast Cancer 3.
HIV Vaccine Field Trials In Advanced Stage4.
Twin Treatment Could Be Used Increase Survival Rates In Advanced Melanoma5.
Eddie Thompson Receives Advanced Cancer Treatment6.
PSA Can Predicts The Treatment Response In Advanced Prostate Cancer7.
Rapid Aging of Arteries In People With Advanced Heart Disease8.
Aricept Cleared for Advanced Alzheimers Treatment9.
Adding Radiation Therapy For Treatment of Advanced Prostate Cancer May Offer Benefit10.
New Pill for Patients With Advanced Prostate Cancer11.
Hormone Drug Type Makes Survival Difference in Advanced Breast Cancer